Douglas W. Blayney

Medical oncologist, Breast specialist

Professor of Medicine (Oncology) at the Stanford University Medical Center

Breast Cancer Program

  • 900 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6004
Learn More About the Clinic Getting Here Make An Appointment

Women's Cancer Center

  • 900 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6004
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Residency: UCSD School of Medicine (06/1980) CA

Medical Education: UC San Diego School of Medicine (06/1977) CA

Fellowship: National Cancer Institute - Center Cancer Research (08/1983) MD

Board Certification: Medical Oncology, American Board of Internal Medicine (1983)

Board Certification: Internal Medicine, American Board of Internal Medicine (1980)

Fellowship, Medicine Branch, National Cancer Institute, Bethesda, Maryland (1983)

Fellowship, Environmental Epidemiology Branch, National Cancer Institute, Bethesda, Maryland (1983)

Resident, University of California Hospitals, San Diego (1980)

M.D., University of California, San Diego (1977)

B.S.E.E., Stanford University (1972)

Honors & Awards

President, American Society of Clinical Oncology (2009-10)

Administrative Appointments

Medical Director, Stanford Cancer Center (2010 - Present)

Medical Director, University of Michigan Comprehensive Cancer Center (2003 - 2010)

President, Wilshire Oncology Medical Group, Inc. (1996 - 2003)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Transforming cancer care: are transdisciplinary approaches using design-thinking, engineering, and business methodologies needed to improve value in cancer care delivery?
Patel, M. I., Moore, D., Blayney, D. W., & Milstein, A. (2014). Transforming cancer care: are transdisciplinary approaches using design-thinking, engineering, and business methodologies needed to improve value in cancer care delivery?. Journal of oncology practice / American Society of Clinical Oncology, 10(2), e51-4.

Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research.
Kurian, A. W., Mitani, A., Desai, M., Yu, P. P., Seto, T., & Das, A. K. (2014). Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research. Cancer, 120(1), 103-111.

American Society of Clinical Oncology 2013 top five list in oncology.
Schnipper, L. E., Lyman, G. H., Blayney, D. W., Hoverman, J. R., Raghavan, D., & Schilsky, R. L. (2013). American Society of Clinical Oncology 2013 top five list in oncology. Journal of clinical oncology , 31(34), 4362-4370.

ASCO's Quality Care Symposium (November 1-2, 2013) Abstracts
Kuznetsov, J. L., Bailey, K., Bombach, P. K., Carmichael, S., Chen, X., & Blayney, D. W. (2013). ASCO's Quality Care Symposium (November 1-2, 2013) Abstracts. JOURNAL OF CLINICAL ONCOLOGY, 31(31).

Computerized prescriber order entry implementation in a physician assistant-managed hematology and oncology inpatient service: effects on workflow and task switching.
Hanauer, D. A., Zheng, K., Commiskey, E. L., Duck, M. G., Choi, S. W., & Blayney, D. W. (2013). Computerized prescriber order entry implementation in a physician assistant-managed hematology and oncology inpatient service: effects on workflow and task switching. Journal of oncology practice / American Society of Clinical Oncology, 9(4), e103-14.

Measuring the Improving Quality of Outpatient Care in Medical Oncology Practices in the United States
Neuss, M. N., Malin, J. L., Chan, S., Kadlubek, P. J., Adams, J. L., & Simone, J. V. (2013). Measuring the Improving Quality of Outpatient Care in Medical Oncology Practices in the United States. JOURNAL OF CLINICAL ONCOLOGY, 31(11), 1471-1477.

Tumor Boards (Team Huddles) Aren't Enough to Reach the Goal
Blayney, D. W. (2013). Tumor Boards (Team Huddles) Aren't Enough to Reach the Goal. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 105(2), 82-84.

Adoption of Gene Expression Profile Testing and Association With Use of Chemotherapy Among Women With Breast Cancer
Hassett, M. J., Silver, S. M., Hughes, M. E., Blayney, D. W., Edge, S. B., & Weeks, J. C. (2012). Adoption of Gene Expression Profile Testing and Association With Use of Chemotherapy Among Women With Breast Cancer. JOURNAL OF CLINICAL ONCOLOGY, 30(18), 2218-2226.

American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology
Schnipper, L. E., Smith, T. J., Raghavan, D., Blayney, D. W., Ganz, P. A., & Wollins, D. S. (2012). American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology. JOURNAL OF CLINICAL ONCOLOGY, 30(14), 1715-1724.

Michigan Oncology Practices Showed Varying Adherence Rates To Practice Guidelines, But Quality Interventions Improved Care
Blayney, D. W., Severson, J., Martin, C. J., Kadlubek, P., Ruane, T., & Harrison, K. (2012). Michigan Oncology Practices Showed Varying Adherence Rates To Practice Guidelines, But Quality Interventions Improved Care. HEALTH AFFAIRS, 31(4), 718-728.

Enhancing Quality Through Innovation: American Society of Clinical Oncology Presidential Address 2010
Blayney, D. W. (2010). Enhancing Quality Through Innovation: American Society of Clinical Oncology Presidential Address 2010. JOURNAL OF CLINICAL ONCOLOGY, 28(28), 4283-4288.

Implementation of the Quality Oncology Practice Initiative at a University Comprehensive Cancer Center
Blayney, D. W., McNiff, K., Hanauer, D., Miela, G., Markstrom, D., & Neuss, M. (2009). Implementation of the Quality Oncology Practice Initiative at a University Comprehensive Cancer Center. JOURNAL OF CLINICAL ONCOLOGY, 27(23), 3802-3807.

Breast Cancer Treatment Across Health Care Systems
Kurian, A. W., Mitani, A., Desai, M., Yu, P. P., Seto, T., & Das, A. K. (2014). Breast Cancer Treatment Across Health Care Systems. CANCER, 120(1), 103-111.

Myeloid Growth Factors
Crawford, J., Armitage, J., Balducci, L., Becker, P. S., Blayney, D. W., & Ho, M. (2013). Myeloid Growth Factors. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 11(10), 1266-1290.

Measuring and improving quality of care in an academic medical center.
Blayney, D. W. (2013). Measuring and improving quality of care in an academic medical center. Journal of oncology practice / American Society of Clinical Oncology, 9(3), 138-141.

Time to diagnosis and breast cancer stage by race/ethnicity
Warner, E. T., Tamimi, R. M., Hughes, M. E., Ottesen, R. A., Wong, Y.-N., & Partridge, A. H. (2012). Time to diagnosis and breast cancer stage by race/ethnicity. BREAST CANCER RESEARCH AND TREATMENT, 136(3), 813-821.

Clinicopathologic Features, Patterns of Recurrence, and Survival Among Women With Triple-Negative Breast Cancer in the National Comprehensive Cancer Network
Lin, N. U., Vanderplas, A., Hughes, M. E., Theriault, R. L., Edge, S. B., & Weeks, J. C. (2012). Clinicopathologic Features, Patterns of Recurrence, and Survival Among Women With Triple-Negative Breast Cancer in the National Comprehensive Cancer Network. CANCER, 118(22), 5463-5472.

The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy
Kleinman, L., Benjamin, K., Viswanathan, H., Mattera, M. S., Bosserman, L., & Revicki, D. A. (2012). The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy. QUALITY OF LIFE RESEARCH, 21(7), 1255-1266.

The Effect of Age on Delay in Diagnosis and Stage of Breast Cancer
Partridge, A. H., Hughes, M. E., Ottesen, R. A., Wong, Y.-N., Edge, S. B., & Tamimi, R. M. (2012). The Effect of Age on Delay in Diagnosis and Stage of Breast Cancer. ONCOLOGIST, 17(6), 775-782.

Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database
LaCasce, A. S., Vandergrift, J. L., Rodriguez, M. A., Abel, G. A., Crosby, A. L., & Friedberg, J. W. (2012). Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database. BLOOD, 119(9), 2093-2099.

The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers
Brewster, A. M., Etzel, C., Zhou, R., Wong, Y., Edge, S., & Theriault, R. L. (2011). The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers. BREAST CANCER RESEARCH AND TREATMENT, 130(3), 897-904.

Commentary: six years of trends in oncology practice data.
Blayney, D. W. (2011). Commentary: six years of trends in oncology practice data. Journal of oncology practice / American Society of Clinical Oncology, 7(5), 291-293.

Myeloid Growth Factors
Crawford, J., Allen, J., Armitage, J., Blayney, D. W., Cataland, S. R., & Westmoreland, M. (2011). Myeloid Growth Factors. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 9(8), 914-?.

Institutional Variation in the Surgical Treatment of Breast Cancer A Study of the NCCN
Greenberg, C. C., Lipsitz, S. R., Hughes, M. E., Edge, S. B., Theriault, R., & Weeks, J. C. (2011). Institutional Variation in the Surgical Treatment of Breast Cancer A Study of the NCCN. ANNALS OF SURGERY, 254(2), 339-345.

Continued Use of Trastuzumab Beyond Disease Progression in the National Comprehensive Cancer Network: Should We Practice Ahead of the Evidence?
Wong, Y.-N., Ottesen, R. A., Hughes, M. E., Niland, J. C., Theriault, R., & Weeks, J. C. (2011). Continued Use of Trastuzumab Beyond Disease Progression in the National Comprehensive Cancer Network: Should We Practice Ahead of the Evidence?. ONCOLOGIST, 16(5), 559-565.

Expansion of cancer care and control in countries of low and middle income: a call to action
Farmer, P., Frenk, J., Knaul, F. M., Shulman, L. N., Alleyne, G., & Seffrin, J. R. (2010). Expansion of cancer care and control in countries of low and middle income: a call to action. LANCET, 376(9747), 1186-1193.

Challenges to National Cancer Institute-Supported Cooperative Group Clinical Trial Participation: An ASCO Survey of Cooperative Group Sites.
Baer, A. R., Kelly, C. A., Bruinooge, S. S., Runowicz, C. D., & Blayney, D. W. (2010). Challenges to National Cancer Institute-Supported Cooperative Group Clinical Trial Participation: An ASCO Survey of Cooperative Group Sites. Journal of oncology practice / American Society of Clinical Oncology, 6(3), 114-117.

Partnering with payers for success: quality oncology practice initiative, blue cross blue shield of michigan, and the michigan oncology quality consortium.
Blayney, D. W., Stella, P. J., Ruane, T., Martin, J., Lavasseur, B., & Malloy, M. (2009). Partnering with payers for success: quality oncology practice initiative, blue cross blue shield of michigan, and the michigan oncology quality consortium. Journal of oncology practice / American Society of Clinical Oncology, 5(6), 281-284.

Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy, and Survival at a Transplantation Center
Knight, J. S., Tsodikov, A., Cibrik, D. M., Ross, C. W., Kaminski, M. S., & Blayney, D. W. (2009). Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy, and Survival at a Transplantation Center. JOURNAL OF CLINICAL ONCOLOGY, 27(20), 3354-3362.

Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer
Hassett, M. J., Hughes, M. E., Niland, J. C., Edge, S. B., Theriault, R. L., & Weeks, J. C. (2008). Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer. JOURNAL OF CLINICAL ONCOLOGY, 26(34), 5553-5560.

The registry case finding engine: An automated tool to identify cancer cases from unstructured, free-text pathology reports and clinical notes.
Hanauer, D. A., Miela, G., Chinnaiyan, A. M., Chang, A. E., & Blayney, D. W. (2007). The registry case finding engine: An automated tool to identify cancer cases from unstructured, free-text pathology reports and clinical notes. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 205(5), 690-697.

Defining Quality: QOPI Is a Start.
Blayney, D. W. (2006). Defining Quality: QOPI Is a Start. Journal of oncology practice / American Society of Clinical Oncology, 2(5), 203-?.

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: A phase II study of the Southwest Oncology Group (SWOG 9349)
Blayney, D. W., LeBlanc, M. L., Grogan, T., GAYNOR, E. R., Chapman, R. A., & Fisher, R. I. (2003). Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: A phase II study of the Southwest Oncology Group (SWOG 9349). JOURNAL OF CLINICAL ONCOLOGY, 21(13), 2466-2473.

DECREASING RISK OF LEUKEMIA WITH PROLONGED FOLLOW-UP AFTER CHEMOTHERAPY AND RADIOTHERAPY FOR HODGKINS-DISEASE
Blayney, D. W., Longo, D. L., Young, R. C., Greene, M. H., Hubbard, S. M., & DeVita, V. T. (1987). DECREASING RISK OF LEUKEMIA WITH PROLONGED FOLLOW-UP AFTER CHEMOTHERAPY AND RADIOTHERAPY FOR HODGKINS-DISEASE. NEW ENGLAND JOURNAL OF MEDICINE, 316(12), 710-714.

THE HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUS IN THE SOUTHEASTERN UNITED-STATES
Blayney, D. W., Blattner, W. A., ROBERTGUROFF, M., Jaffe, E. S., Fisher, R. I., & Gallo, R. C. (1983). THE HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUS IN THE SOUTHEASTERN UNITED-STATES. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 250(8), 1048-1052.

THE HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS, LYMPHOMA, LYTIC BONE-LESIONS, AND HYPERCALCEMIA
Blayney, D. W., Jaffe, E. S., Fisher, R. I., Schechter, G. P., Cossman, J., & Gallo, R. C. (1983). THE HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS, LYMPHOMA, LYTIC BONE-LESIONS, AND HYPERCALCEMIA. ANNALS OF INTERNAL MEDICINE, 98(2), 144-151.

THE HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS ASSOCIATED WITH AMERICAN ADULT T-CELL LEUKEMIA LYMPHOMA
Blayney, D. W., Jaffe, E. S., Blattner, W. A., Cossman, J., ROBERTGUROFF, M., & Gallo, R. C. (1983). THE HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS ASSOCIATED WITH AMERICAN ADULT T-CELL LEUKEMIA LYMPHOMA. BLOOD, 62(2), 401-405.